

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal rod cell development (GO:0046548) | 9.71841915 |
| 2 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.61250430 |
| 3 | * visual perception (GO:0007601) | 8.75425642 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 8.69069026 |
| 5 | * sensory perception of light stimulus (GO:0050953) | 8.65232349 |
| 6 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 8.49728929 |
| 7 | negative regulation of heart growth (GO:0061117) | 8.49728929 |
| 8 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 8.25382583 |
| 9 | negative regulation of muscle hypertrophy (GO:0014741) | 7.39782081 |
| 10 | * cellular response to light stimulus (GO:0071482) | 7.27605241 |
| 11 | * detection of external stimulus (GO:0009581) | 7.07745794 |
| 12 | response to electrical stimulus (GO:0051602) | 6.96275197 |
| 13 | * detection of abiotic stimulus (GO:0009582) | 6.93480910 |
| 14 | photoreceptor cell differentiation (GO:0046530) | 6.91442030 |
| 15 | eye photoreceptor cell differentiation (GO:0001754) | 6.91442030 |
| 16 | * protein-chromophore linkage (GO:0018298) | 6.89926133 |
| 17 | regulation of cGMP metabolic process (GO:0030823) | 6.39377454 |
| 18 | * retina development in camera-type eye (GO:0060041) | 5.89851685 |
| 19 | fat-soluble vitamin metabolic process (GO:0006775) | 5.69748943 |
| 20 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.63200891 |
| 21 | negative regulation of cardiac muscle tissue development (GO:0055026) | 5.61307171 |
| 22 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.61257614 |
| 23 | retinal metabolic process (GO:0042574) | 5.47043088 |
| 24 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.40444924 |
| 25 | regulation of cGMP biosynthetic process (GO:0030826) | 5.28981674 |
| 26 | positive regulation of cGMP metabolic process (GO:0030825) | 4.96626176 |
| 27 | adaptation of signaling pathway (GO:0023058) | 4.89954911 |
| 28 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.79730643 |
| 29 | regulation of cardiac muscle cell differentiation (GO:2000725) | 4.75391832 |
| 30 | sensory perception of taste (GO:0050909) | 4.71609299 |
| 31 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.67252809 |
| 32 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.66549665 |
| 33 | * cellular response to radiation (GO:0071478) | 4.66177853 |
| 34 | nonmotile primary cilium assembly (GO:0035058) | 4.59692288 |
| 35 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.45868045 |
| 36 | keratan sulfate catabolic process (GO:0042340) | 4.27682560 |
| 37 | estrogen biosynthetic process (GO:0006703) | 4.22384130 |
| 38 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.15173682 |
| 39 | prenylation (GO:0097354) | 4.12269627 |
| 40 | protein prenylation (GO:0018342) | 4.12269627 |
| 41 | * sensory perception (GO:0007600) | 4.09652075 |
| 42 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.07740217 |
| 43 | retina layer formation (GO:0010842) | 3.89300127 |
| 44 | * response to light stimulus (GO:0009416) | 3.86970028 |
| 45 | negative regulation of striated muscle cell differentiation (GO:0051154) | 3.82304542 |
| 46 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.70959093 |
| 47 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.65201913 |
| 48 | neuron development (GO:0048666) | 3.61869721 |
| 49 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.60825646 |
| 50 | retina homeostasis (GO:0001895) | 3.58497923 |
| 51 | regulation of muscle hypertrophy (GO:0014743) | 3.56085703 |
| 52 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.54258234 |
| 53 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.39375345 |
| 54 | short-term memory (GO:0007614) | 3.38380102 |
| 55 | protein localization to synapse (GO:0035418) | 3.34342126 |
| 56 | negative regulation of organ growth (GO:0046621) | 3.29864299 |
| 57 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29409038 |
| 58 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.27640553 |
| 59 | chemosensory behavior (GO:0007635) | 3.25511646 |
| 60 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.25448495 |
| 61 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23379539 |
| 62 | membrane hyperpolarization (GO:0060081) | 3.21674348 |
| 63 | behavioral response to ethanol (GO:0048149) | 3.20773443 |
| 64 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.18020886 |
| 65 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.18020886 |
| 66 | cellular response to zinc ion (GO:0071294) | 3.13624274 |
| 67 | regulation of penile erection (GO:0060405) | 3.12945463 |
| 68 | synaptic vesicle maturation (GO:0016188) | 3.08106015 |
| 69 | response to histamine (GO:0034776) | 3.08042257 |
| 70 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.07645160 |
| 71 | * terpenoid metabolic process (GO:0006721) | 3.06377454 |
| 72 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.03900621 |
| 73 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.03663579 |
| 74 | phospholipid translocation (GO:0045332) | 3.02695442 |
| 75 | lipid translocation (GO:0034204) | 3.02695442 |
| 76 | vitamin A metabolic process (GO:0006776) | 23.2948900 |
| 77 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.94472290 |
| 78 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.91152124 |
| 79 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.87823556 |
| 80 | positive regulation of lyase activity (GO:0051349) | 2.86231655 |
| 81 | negative regulation of striated muscle tissue development (GO:0045843) | 2.81935725 |
| 82 | regulation of muscle adaptation (GO:0043502) | 2.81390540 |
| 83 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.79144163 |
| 84 | * retinoid metabolic process (GO:0001523) | 2.71872363 |
| 85 | negative regulation of muscle tissue development (GO:1901862) | 2.71565998 |
| 86 | post-embryonic morphogenesis (GO:0009886) | 2.68855067 |
| 87 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.68135273 |
| 88 | negative regulation of cation channel activity (GO:2001258) | 2.67413373 |
| 89 | lipoprotein transport (GO:0042953) | 2.66861547 |
| 90 | arachidonic acid secretion (GO:0050482) | 2.64470761 |
| 91 | icosanoid secretion (GO:0032309) | 2.64470761 |
| 92 | * response to radiation (GO:0009314) | 2.63710233 |
| 93 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.62970867 |
| 94 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.62970867 |
| 95 | dopamine receptor signaling pathway (GO:0007212) | 2.62377641 |
| 96 | negative regulation of muscle organ development (GO:0048635) | 2.62277096 |
| 97 | primary alcohol metabolic process (GO:0034308) | 2.61590416 |
| 98 | negative regulation of catenin import into nucleus (GO:0035414) | 2.60996468 |
| 99 | axoneme assembly (GO:0035082) | 2.57044074 |
| 100 | retinol metabolic process (GO:0042572) | 2.55890793 |
| 101 | regulation of cardiac muscle tissue growth (GO:0055021) | 2.54438163 |
| 102 | * diterpenoid metabolic process (GO:0016101) | 2.52525742 |
| 103 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.49150782 |
| 104 | behavioral response to cocaine (GO:0048148) | 2.48080249 |
| 105 | * isoprenoid metabolic process (GO:0006720) | 2.47450504 |
| 106 | barbed-end actin filament capping (GO:0051016) | 2.43527598 |
| 107 | righting reflex (GO:0060013) | 2.42817526 |
| 108 | vasculature development (GO:0001944) | 2.40799933 |
| 109 | positive regulation of cyclase activity (GO:0031281) | 2.40382776 |
| 110 | mitochondrion transport along microtubule (GO:0047497) | 2.40059628 |
| 111 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.40059628 |
| 112 | synaptic transmission, dopaminergic (GO:0001963) | 2.38141685 |
| 113 | cellular potassium ion homeostasis (GO:0030007) | 2.37909822 |
| 114 | * cellular response to abiotic stimulus (GO:0071214) | 2.35557973 |
| 115 | extracellular fibril organization (GO:0043206) | 2.34979855 |
| 116 | low-density lipoprotein particle remodeling (GO:0034374) | 2.34803885 |
| 117 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.34715007 |
| 118 | protein heterotetramerization (GO:0051290) | 2.33243717 |
| 119 | smooth muscle tissue development (GO:0048745) | 2.32798057 |
| 120 | cellular response to cadmium ion (GO:0071276) | 2.30769215 |
| 121 | regulation of lipoprotein metabolic process (GO:0050746) | 2.29743752 |
| 122 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.26937239 |
| 123 | quaternary ammonium group transport (GO:0015697) | 2.19528958 |
| 124 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.18721869 |
| 125 | regulation of heart growth (GO:0060420) | 2.15156610 |
| 126 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.11739716 |
| 127 | actin-myosin filament sliding (GO:0033275) | 2.11107804 |
| 128 | muscle filament sliding (GO:0030049) | 2.11107804 |
| 129 | modified amino acid transport (GO:0072337) | 2.10781304 |
| 130 | sensory perception of chemical stimulus (GO:0007606) | 2.09907843 |
| 131 | lymph vessel development (GO:0001945) | 2.09095607 |
| 132 | negative regulation of muscle cell differentiation (GO:0051148) | 2.06772254 |
| 133 | cell-cell junction maintenance (GO:0045217) | 2.04142590 |
| 134 | negative regulation of developmental growth (GO:0048640) | 2.03860499 |
| 135 | gamma-aminobutyric acid transport (GO:0015812) | 2.00867886 |
| 136 | cellular response to electrical stimulus (GO:0071257) | 17.9923794 |
| 137 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.8363495 |
| 138 | * rhodopsin mediated signaling pathway (GO:0016056) | 17.5884716 |
| 139 | retinal cone cell development (GO:0046549) | 15.4937927 |
| 140 | photoreceptor cell development (GO:0042461) | 12.3089726 |
| 141 | photoreceptor cell maintenance (GO:0045494) | 11.8224749 |
| 142 | eye photoreceptor cell development (GO:0042462) | 11.6405130 |
| 143 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.4263971 |
| 144 | detection of light stimulus involved in visual perception (GO:0050908) | 11.4263971 |
| 145 | * phototransduction (GO:0007602) | 10.7375244 |
| 146 | * phototransduction, visible light (GO:0007603) | 10.6337171 |
| 147 | GMP metabolic process (GO:0046037) | 10.1358498 |
| 148 | * detection of light stimulus (GO:0009583) | 10.1330641 |
| 149 | * detection of visible light (GO:0009584) | 10.1182310 |
| 150 | regulation of cyclase activity (GO:0031279) | 1.99030251 |
| 151 | positive regulation of cyclic nucleotide biosynthetic process (GO:0030804) | 1.95053387 |
| 152 | fibril organization (GO:0097435) | 1.94722507 |
| 153 | keratan sulfate biosynthetic process (GO:0018146) | 1.94527561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 5.85894935 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 5.07546442 |
| 3 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.28895132 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.19386772 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.16577324 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.81601966 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53180955 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.44744205 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36162684 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17883798 |
| 11 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.15422870 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.07352726 |
| 13 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.06817251 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98366327 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91701102 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.88794626 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84053715 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83616243 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.81901734 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80639300 |
| 21 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.79705105 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77547951 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.75154013 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72735522 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72562870 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67909710 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67751231 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64720768 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64564619 |
| 30 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.64224050 |
| 31 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.64224050 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63640353 |
| 33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.63589017 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63201434 |
| 35 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61842512 |
| 36 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.61276248 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60605972 |
| 38 | AR_19668381_ChIP-Seq_PC3_Human | 1.59035929 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58918051 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56473843 |
| 41 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.48592194 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48511239 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46876638 |
| 44 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.46304891 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46267607 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44389176 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43423489 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43423489 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41751348 |
| 50 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.39297801 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37286574 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36784039 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35756702 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35612086 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32655434 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32339108 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32184266 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31576592 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31484828 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30191179 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.29868596 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28461298 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28322175 |
| 64 | TBL1_22424771_ChIP-Seq_293T_Human | 1.27270162 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26087184 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25648275 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24527485 |
| 68 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.24028733 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22978762 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21900573 |
| 71 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.21441596 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21143952 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20003859 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19836272 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19541108 |
| 76 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.19488966 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18457405 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17130160 |
| 79 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.16690734 |
| 80 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.16441389 |
| 81 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15988981 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15287351 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14250308 |
| 84 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.12099698 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11924657 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11793593 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11619949 |
| 88 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.11159762 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10568209 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08695888 |
| 91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08253233 |
| 92 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07210580 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06656033 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06601763 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05119202 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05056253 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.04517753 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03470183 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03078959 |
| 100 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.02128193 |
| 101 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02018570 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02014538 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01314007 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00994290 |
| 105 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00899062 |
| 106 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00295344 |
| 107 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00295344 |
| 108 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00295344 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00106981 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99805929 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99778741 |
| 112 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99713425 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99575841 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99495595 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98922638 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96096805 |
| 117 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95896409 |
| 118 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95887214 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95835619 |
| 120 | CBP_21632823_ChIP-Seq_H3396_Human | 0.95450945 |
| 121 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94739309 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94237944 |
| 123 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93935608 |
| 124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93907797 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93691874 |
| 126 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93687878 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93373675 |
| 128 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93322490 |
| 129 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93172832 |
| 130 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93047957 |
| 131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92965997 |
| 132 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.92627825 |
| 133 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92515288 |
| 134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.92462058 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92209845 |
| 136 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92090226 |
| 137 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92050028 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91765096 |
| 139 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.91052130 |
| 140 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90595403 |
| 141 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.90479729 |
| 142 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.89802605 |
| 143 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89743357 |
| 144 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89399280 |
| 145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89111277 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88860690 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88191671 |
| 148 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86713117 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86691455 |
| 150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85801713 |
| 151 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85651366 |
| 152 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85585169 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85531067 |
| 154 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.85132444 |
| 155 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84805678 |
| 156 | * P68_20966046_ChIP-Seq_HELA_Human | 0.84787904 |
| 157 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84483193 |
| 158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84228705 |
| 159 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83763274 |
| 160 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83655921 |
| 161 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83569177 |
| 162 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82261569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003011_delayed_dark_adaptation | 8.98230295 |
| 2 | * MP0005253_abnormal_eye_physiology | 7.36273999 |
| 3 | * MP0006072_abnormal_retinal_apoptosis | 6.04531405 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.25983013 |
| 5 | * MP0005195_abnormal_posterior_eye | 4.23253729 |
| 6 | * MP0005391_vision/eye_phenotype | 3.54833241 |
| 7 | * MP0001324_abnormal_eye_pigmentation | 3.46986818 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.28740297 |
| 9 | MP0002638_abnormal_pupillary_reflex | 3.04988177 |
| 10 | * MP0002229_neurodegeneration | 2.88250664 |
| 11 | * MP0002090_abnormal_vision | 2.43043870 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.42285827 |
| 13 | * MP0002752_abnormal_somatic_nervous | 2.10272185 |
| 14 | * MP0005551_abnormal_eye_electrophysiolog | 10.6793231 |
| 15 | MP0002653_abnormal_ependyma_morphology | 1.81014701 |
| 16 | * MP0002882_abnormal_neuron_morphology | 1.56009818 |
| 17 | * MP0001764_abnormal_homeostasis | 1.34285867 |
| 18 | MP0004233_abnormal_muscle_weight | 1.29675737 |
| 19 | MP0004270_analgesia | 1.23048023 |
| 20 | MP0005275_abnormal_skin_tensile | 1.20457021 |
| 21 | MP0004885_abnormal_endolymph | 1.14726337 |
| 22 | MP0001502_abnormal_circadian_rhythm | 1.14571743 |
| 23 | MP0005197_abnormal_uvea_morphology | 1.10336145 |
| 24 | MP0005171_absent_coat_pigmentation | 1.10107086 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.07786399 |
| 26 | MP0001984_abnormal_olfaction | 1.07644212 |
| 27 | MP0001486_abnormal_startle_reflex | 1.02045420 |
| 28 | MP0002332_abnormal_exercise_endurance | 0.94870693 |
| 29 | MP0003634_abnormal_glial_cell | 0.91097336 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 0.90391614 |
| 31 | MP0003880_abnormal_central_pattern | 0.88743474 |
| 32 | MP0002272_abnormal_nervous_system | 0.87555568 |
| 33 | MP0005499_abnormal_olfactory_system | 0.87247076 |
| 34 | MP0005394_taste/olfaction_phenotype | 0.87247076 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 0.85325223 |
| 36 | MP0006292_abnormal_olfactory_placode | 0.82888585 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 0.79948072 |
| 38 | MP0005187_abnormal_penis_morphology | 0.79517659 |
| 39 | MP0003136_yellow_coat_color | 0.77923672 |
| 40 | MP0003724_increased_susceptibility_to | 0.72351018 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 0.69366977 |
| 42 | MP0009046_muscle_twitch | 0.68464502 |
| 43 | MP0002933_joint_inflammation | 0.68282578 |
| 44 | MP0002064_seizures | 0.67946637 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 0.67710350 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 0.67226490 |
| 47 | MP0008789_abnormal_olfactory_epithelium | 0.65604605 |
| 48 | * MP0004019_abnormal_vitamin_homeostasis | 0.64747922 |
| 49 | MP0001963_abnormal_hearing_physiology | 0.52818025 |
| 50 | MP0002075_abnormal_coat/hair_pigmentati | 0.50836797 |
| 51 | MP0002063_abnormal_learning/memory/cond | 0.50393911 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 0.50202803 |
| 53 | MP0001968_abnormal_touch/_nociception | 0.49406906 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 0.48322761 |
| 55 | MP0002067_abnormal_sensory_capabilities | 0.47419029 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 0.45078557 |
| 57 | MP0004924_abnormal_behavior | 0.44709234 |
| 58 | MP0005386_behavior/neurological_phenoty | 0.44709234 |
| 59 | MP0008004_abnormal_stomach_pH | 0.44542325 |
| 60 | MP0009745_abnormal_behavioral_response | 0.44501995 |
| 61 | MP0005409_darkened_coat_color | 0.43718563 |
| 62 | MP0004215_abnormal_myocardial_fiber | 0.41888544 |
| 63 | MP0005508_abnormal_skeleton_morphology | 0.41588449 |
| 64 | MP0000372_irregular_coat_pigmentation | 0.41576734 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.40525498 |
| 66 | MP0003045_fibrosis | 0.38823258 |
| 67 | MP0004272_abnormal_basement_membrane | 0.38404372 |
| 68 | MP0004742_abnormal_vestibular_system | 0.38379468 |
| 69 | MP0001186_pigmentation_phenotype | 0.35724470 |
| 70 | MP0004085_abnormal_heartbeat | 0.35684722 |
| 71 | MP0002249_abnormal_larynx_morphology | 0.35513178 |
| 72 | MP0009780_abnormal_chondrocyte_physiolo | 0.35193341 |
| 73 | MP0005623_abnormal_meninges_morphology | 0.35024471 |
| 74 | MP0008569_lethality_at_weaning | 0.34686496 |
| 75 | MP0002697_abnormal_eye_size | 0.34403740 |
| 76 | MP0005620_abnormal_muscle_contractility | 0.34242613 |
| 77 | MP0003300_gastrointestinal_ulcer | 0.34164076 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.33527902 |
| 79 | * MP0001286_abnormal_eye_development | 0.32998551 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.31910415 |
| 81 | MP0004043_abnormal_pH_regulation | 0.30527393 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.29560266 |
| 83 | MP0003878_abnormal_ear_physiology | 0.29560266 |
| 84 | * MP0005376_homeostasis/metabolism_phenot | 0.29339638 |
| 85 | MP0005193_abnormal_anterior_eye | 0.29117560 |
| 86 | MP0000747_muscle_weakness | 0.28857220 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.28604701 |
| 88 | MP0001915_intracranial_hemorrhage | 0.28444224 |
| 89 | MP0002152_abnormal_brain_morphology | 0.28405452 |
| 90 | MP0003252_abnormal_bile_duct | 0.28140224 |
| 91 | MP0002066_abnormal_motor_capabilities/c | 0.27332766 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.26956537 |
| 93 | MP0006138_congestive_heart_failure | 0.26840363 |
| 94 | MP0004142_abnormal_muscle_tone | 0.26299603 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.26072311 |
| 96 | MP0002184_abnormal_innervation | 0.26016632 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.25928649 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.25615658 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.25186236 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.25137222 |
| 101 | MP0005595_abnormal_vascular_smooth | 0.24932283 |
| 102 | MP0000462_abnormal_digestive_system | 0.24433576 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.23975691 |
| 104 | MP0000516_abnormal_urinary_system | 0.23975691 |
| 105 | MP0002822_catalepsy | 0.23405653 |
| 106 | MP0000749_muscle_degeneration | 0.23172864 |
| 107 | MP0004036_abnormal_muscle_relaxation | 0.23110029 |
| 108 | MP0000026_abnormal_inner_ear | 0.23074827 |
| 109 | MP0002102_abnormal_ear_morphology | 0.22371994 |
| 110 | MP0001958_emphysema | 0.22181603 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.22055667 |
| 112 | MP0009764_decreased_sensitivity_to | 0.21892715 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.21522180 |
| 114 | MP0000778_abnormal_nervous_system | 0.21358547 |
| 115 | MP0004084_abnormal_cardiac_muscle | 0.21065854 |
| 116 | MP0003632_abnormal_nervous_system | 0.21011145 |
| 117 | MP0003633_abnormal_nervous_system | 0.20932049 |
| 118 | MP0003646_muscle_fatigue | 0.20839414 |
| 119 | MP0002009_preneoplasia | 0.20297293 |
| 120 | MP0003890_abnormal_embryonic-extraembry | 0.20188192 |
| 121 | MP0001905_abnormal_dopamine_level | 0.20028112 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.19854320 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.19462499 |
| 124 | MP0002928_abnormal_bile_duct | 0.19171237 |
| 125 | MP0005390_skeleton_phenotype | 0.19127662 |
| 126 | MP0003075_altered_response_to | 0.19118741 |
| 127 | MP0005165_increased_susceptibility_to | 0.19086100 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.18677935 |
| 129 | MP0002092_abnormal_eye_morphology | 0.18573859 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.18247357 |
| 131 | MP0006054_spinal_hemorrhage | 0.18187734 |
| 132 | MP0000343_altered_response_to | 0.17969779 |
| 133 | MP0003631_nervous_system_phenotype | 0.16609613 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.16541452 |
| 135 | MP0005023_abnormal_wound_healing | 0.16397803 |
| 136 | MP0000249_abnormal_blood_vessel | 0.16137970 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.15797300 |
| 138 | MP0005330_cardiomyopathy | 0.15716103 |
| 139 | MP0000751_myopathy | 0.15517479 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.15137992 |
| 141 | MP0001177_atelectasis | 0.15119529 |
| 142 | MP0000163_abnormal_cartilage_morphology | 0.14597200 |
| 143 | MP0001970_abnormal_pain_threshold | 0.14159398 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.14149732 |
| 145 | MP0002938_white_spotting | 0.13942339 |
| 146 | MP0003566_abnormal_cell_adhesion | 0.13902543 |
| 147 | MP0001661_extended_life_span | 0.13625360 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.13129331 |
| 149 | MP0000920_abnormal_myelination | 0.13036427 |
| 150 | MP0001879_abnormal_lymphatic_vessel | 0.12815486 |
| 151 | MP0000534_abnormal_ureter_morphology | 0.12356574 |
| 152 | MP0002128_abnormal_blood_circulation | 0.12031657 |
| 153 | MP0009250_abnormal_appendicular_skeleto | 0.11648447 |
| 154 | MP0001851_eye_inflammation | 0.11273606 |
| 155 | MP0005408_hypopigmentation | 0.11043720 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.10697047 |
| 157 | MP0005369_muscle_phenotype | 0.10600992 |
| 158 | MP0003279_aneurysm | 0.10595165 |
| 159 | MP0001727_abnormal_embryo_implantation | 0.09662057 |
| 160 | MP0003828_pulmonary_edema | 0.09171868 |
| 161 | MP0001533_abnormal_skeleton_physiology | 0.08415619 |
| 162 | MP0000759_abnormal_skeletal_muscle | 0.08243702 |
| 163 | MP0002282_abnormal_trachea_morphology | 0.07969627 |
| 164 | MP0004484_altered_response_of | 0.07854269 |
| 165 | MP0004087_abnormal_muscle_fiber | 0.07853711 |
| 166 | MP0003091_abnormal_cell_migration | 0.07378783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 9.25769546 |
| 2 | Dyschromatopsia (HP:0007641) | 9.10432057 |
| 3 | Central scotoma (HP:0000603) | 8.97581930 |
| 4 | Chorioretinal atrophy (HP:0000533) | 8.47236076 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 8.19415695 |
| 6 | Scotoma (HP:0000575) | 8.00392922 |
| 7 | Pendular nystagmus (HP:0012043) | 7.96272934 |
| 8 | Attenuation of retinal blood vessels (HP:0007843) | 7.73232446 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 6.87599571 |
| 10 | Decreased central vision (HP:0007663) | 6.77342480 |
| 11 | * Photophobia (HP:0000613) | 5.63928956 |
| 12 | * Type II diabetes mellitus (HP:0005978) | 5.48045918 |
| 13 | Macular degeneration (HP:0000608) | 5.45679355 |
| 14 | Vitreoretinal degeneration (HP:0000655) | 5.29243841 |
| 15 | Increased corneal curvature (HP:0100692) | 5.00468966 |
| 16 | Keratoconus (HP:0000563) | 5.00468966 |
| 17 | Severe visual impairment (HP:0001141) | 4.92863155 |
| 18 | Posterior subcapsular cataract (HP:0007787) | 4.92630190 |
| 19 | Cone-rod dystrophy (HP:0000548) | 4.78786285 |
| 20 | Choroideremia (HP:0001139) | 4.76301818 |
| 21 | Constricted visual fields (HP:0001133) | 4.57574809 |
| 22 | * Retinitis pigmentosa (HP:0000510) | 4.07532155 |
| 23 | Ulnar claw (HP:0001178) | 3.49111148 |
| 24 | Progressive visual loss (HP:0000529) | 3.34453764 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.22061641 |
| 26 | Retinal atrophy (HP:0001105) | 3.18579977 |
| 27 | Subcapsular cataract (HP:0000523) | 2.99608181 |
| 28 | Complement deficiency (HP:0004431) | 2.84007536 |
| 29 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.78622686 |
| 30 | Congenital sensorineural hearing impairment (HP:0008527) | 2.70975280 |
| 31 | Action tremor (HP:0002345) | 2.67615424 |
| 32 | Insidious onset (HP:0003587) | 2.62199252 |
| 33 | Termporal pattern (HP:0011008) | 2.62199252 |
| 34 | Optic disc pallor (HP:0000543) | 2.61547574 |
| 35 | Peripheral hypomyelination (HP:0007182) | 2.58021569 |
| 36 | * Wide nasal bridge (HP:0000431) | 2.43628125 |
| 37 | Hypopigmentation of the fundus (HP:0007894) | 2.43605797 |
| 38 | Abnormality of complement system (HP:0005339) | 2.42762399 |
| 39 | Abnormal pupillary function (HP:0007686) | 2.34596016 |
| 40 | Amyloidosis (HP:0011034) | 2.12017266 |
| 41 | White forelock (HP:0002211) | 2.10757151 |
| 42 | Gait imbalance (HP:0002141) | 2.08106378 |
| 43 | * Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07687772 |
| 44 | Congenital primary aphakia (HP:0007707) | 2.05803235 |
| 45 | * Congenital stationary night blindness (HP:0007642) | 13.9401646 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 11.1677555 |
| 47 | * Bony spicule pigmentary retinopathy (HP:0007737) | 10.8407480 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.4635377 |
| 49 | Hypoplasia of the iris (HP:0007676) | 1.97472715 |
| 50 | Upper limb muscle weakness (HP:0003484) | 1.93779200 |
| 51 | Nemaline bodies (HP:0003798) | 1.93434426 |
| 52 | Glomerulonephritis (HP:0000099) | 1.90112096 |
| 53 | Patchy hypopigmentation of hair (HP:0011365) | 1.82803364 |
| 54 | Muscle fiber inclusion bodies (HP:0100299) | 1.80627315 |
| 55 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80135471 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 1.74625820 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 1.71358255 |
| 58 | Polar cataract (HP:0010696) | 1.66356414 |
| 59 | Increased CSF protein (HP:0002922) | 1.64764772 |
| 60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.64496313 |
| 61 | Horizontal nystagmus (HP:0000666) | 1.63032209 |
| 62 | Calf muscle hypertrophy (HP:0008981) | 1.61955573 |
| 63 | Foot dorsiflexor weakness (HP:0009027) | 1.61542316 |
| 64 | Protrusio acetabuli (HP:0003179) | 1.59312062 |
| 65 | Poor coordination (HP:0002370) | 1.57124963 |
| 66 | Aortic aneurysm (HP:0004942) | 1.55802352 |
| 67 | * Optic atrophy (HP:0000648) | 1.53742856 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 1.53411617 |
| 69 | Postural tremor (HP:0002174) | 1.52621567 |
| 70 | Muscle fiber splitting (HP:0003555) | 1.51241912 |
| 71 | Progressive sensorineural hearing impairment (HP:0000408) | 1.50358526 |
| 72 | Impaired proprioception (HP:0010831) | 1.50207162 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 1.47882246 |
| 74 | Distal arthrogryposis (HP:0005684) | 1.44920347 |
| 75 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.43621751 |
| 76 | Vaginal atresia (HP:0000148) | 1.41853775 |
| 77 | Pulmonary artery stenosis (HP:0004415) | 1.37043408 |
| 78 | Severe Myopia (HP:0011003) | 1.36809867 |
| 79 | True hermaphroditism (HP:0010459) | 1.36355498 |
| 80 | Nephritis (HP:0000123) | 1.35823766 |
| 81 | Distal lower limb muscle weakness (HP:0009053) | 1.35767245 |
| 82 | Genital tract atresia (HP:0001827) | 1.35703680 |
| 83 | Thyroiditis (HP:0100646) | 1.33636154 |
| 84 | Increased connective tissue (HP:0009025) | 1.30493270 |
| 85 | Steppage gait (HP:0003376) | 1.29495970 |
| 86 | Vertebral compression fractures (HP:0002953) | 1.28064098 |
| 87 | Dysdiadochokinesis (HP:0002075) | 1.27405196 |
| 88 | Difficulty running (HP:0009046) | 1.25850286 |
| 89 | Retinal detachment (HP:0000541) | 1.25319156 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 1.24982961 |
| 91 | Pancreatic fibrosis (HP:0100732) | 1.24547907 |
| 92 | Abnormality of the fovea (HP:0000493) | 1.19926794 |
| 93 | Epileptic encephalopathy (HP:0200134) | 1.19923212 |
| 94 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.19385286 |
| 95 | Bulbar palsy (HP:0001283) | 1.17986956 |
| 96 | Asymmetry of the thorax (HP:0001555) | 1.15318686 |
| 97 | Hypoplasia of the fovea (HP:0007750) | 1.14869071 |
| 98 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.14869071 |
| 99 | Heterochromia iridis (HP:0001100) | 1.14668209 |
| 100 | Stereotypic behavior (HP:0000733) | 1.13813563 |
| 101 | Blue irides (HP:0000635) | 1.09721973 |
| 102 | Visual hallucinations (HP:0002367) | 1.09456330 |
| 103 | Absent phalangeal crease (HP:0006109) | 1.07135778 |
| 104 | Cystic liver disease (HP:0006706) | 1.05677602 |
| 105 | Febrile seizures (HP:0002373) | 1.05032587 |
| 106 | Recurrent sinusitis (HP:0011108) | 1.02267764 |
| 107 | Neck muscle weakness (HP:0000467) | 1.00452883 |
| 108 | Astigmatism (HP:0000483) | 1.00190547 |
| 109 | Truncal ataxia (HP:0002078) | 0.98990337 |
| 110 | Bilateral sensorineural hearing impairment (HP:0008619) | 0.98532966 |
| 111 | Pancreatic cysts (HP:0001737) | 0.97295215 |
| 112 | Peripheral demyelination (HP:0011096) | 0.96289118 |
| 113 | Round ear (HP:0100830) | 0.95698319 |
| 114 | Progressive cerebellar ataxia (HP:0002073) | 0.93595733 |
| 115 | Bicornuate uterus (HP:0000813) | 0.93257699 |
| 116 | Onion bulb formation (HP:0003383) | 0.93181204 |
| 117 | Hammertoe (HP:0001765) | 0.93061596 |
| 118 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.90760572 |
| 119 | Ulnar deviation of the wrist (HP:0003049) | 0.90612449 |
| 120 | Lower limb amyotrophy (HP:0007210) | 0.90561540 |
| 121 | Chorioretinal coloboma (HP:0000567) | 0.89494490 |
| 122 | Albinism (HP:0001022) | 0.89305732 |
| 123 | Spontaneous hematomas (HP:0007420) | 0.89305313 |
| 124 | Hemorrhage of the eye (HP:0011885) | 0.88712235 |
| 125 | Hypermetropia (HP:0000540) | 0.87764491 |
| 126 | Annular pancreas (HP:0001734) | 0.87730226 |
| 127 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.86778858 |
| 128 | Left ventricular hypertrophy (HP:0001712) | 0.85637922 |
| 129 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.84831541 |
| 130 | Specific learning disability (HP:0001328) | 0.84575683 |
| 131 | Broad foot (HP:0001769) | 0.83546699 |
| 132 | Prolonged QT interval (HP:0001657) | 0.83246864 |
| 133 | Sclerocornea (HP:0000647) | 0.81325160 |
| 134 | Genetic anticipation (HP:0003743) | 0.79692861 |
| 135 | Furrowed tongue (HP:0000221) | 0.77987309 |
| 136 | Decreased testicular size (HP:0008734) | 0.76585218 |
| 137 | Asthma (HP:0002099) | 0.76465843 |
| 138 | Macroorchidism (HP:0000053) | 0.73301511 |
| 139 | Cerebellar dysplasia (HP:0007033) | 0.71711516 |
| 140 | Corneal dystrophy (HP:0001131) | 0.71002434 |
| 141 | Lymphopenia (HP:0001888) | 0.67869940 |
| 142 | Broad-based gait (HP:0002136) | 0.66606079 |
| 143 | Abnormal EKG (HP:0003115) | 0.65162559 |
| 144 | Abnormality of the fingertips (HP:0001211) | 0.64932213 |
| 145 | Aqueductal stenosis (HP:0002410) | 0.64897325 |
| 146 | Molar tooth sign on MRI (HP:0002419) | 0.63802507 |
| 147 | Abnormality of midbrain morphology (HP:0002418) | 0.63802507 |
| 148 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.63153341 |
| 149 | Anencephaly (HP:0002323) | 0.62877961 |
| 150 | Abnormality of dental color (HP:0011073) | 0.62689660 |
| 151 | Zonular cataract (HP:0010920) | 0.62626352 |
| 152 | Syncope (HP:0001279) | 0.61303869 |
| 153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.61176836 |
| 154 | Generalized myoclonic seizures (HP:0002123) | 0.59270046 |
| 155 | Supranuclear gaze palsy (HP:0000605) | 0.58948184 |
| 156 | Hypoventilation (HP:0002791) | 0.58871384 |
| 157 | Depression (HP:0000716) | 0.58089421 |
| 158 | Dysmetric saccades (HP:0000641) | 0.57455668 |
| 159 | Postaxial hand polydactyly (HP:0001162) | 0.57007484 |
| 160 | Partial agenesis of the corpus callosum (HP:0001338) | 0.56934824 |
| 161 | Dental crowding (HP:0000678) | 0.56600395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 7.80437363 |
| 2 | PBK | 6.86018776 |
| 3 | * GRK1 | 6.46547703 |
| 4 | OBSCN | 4.69310712 |
| 5 | ERN1 | 4.03882606 |
| 6 | TGFBR2 | 3.91413942 |
| 7 | EPHA3 | 3.83521807 |
| 8 | PINK1 | 3.75645048 |
| 9 | IRAK2 | 2.71357449 |
| 10 | TRPM7 | 2.50456954 |
| 11 | SIK2 | 2.44839556 |
| 12 | MAP3K10 | 2.40401403 |
| 13 | EPHB1 | 2.37490635 |
| 14 | CAMK1G | 2.25927738 |
| 15 | CDK12 | 2.05568408 |
| 16 | ADRBK1 | 1.97376252 |
| 17 | CSK | 1.87284447 |
| 18 | CAMK1D | 1.85575884 |
| 19 | TIE1 | 1.81030358 |
| 20 | HIPK2 | 1.79078074 |
| 21 | PAK6 | 1.77716096 |
| 22 | MAPK7 | 1.75205157 |
| 23 | STK39 | 1.74314367 |
| 24 | DDR2 | 1.71877401 |
| 25 | BRD4 | 1.69738767 |
| 26 | PNCK | 1.67612257 |
| 27 | TAOK3 | 1.67494109 |
| 28 | STK38 | 1.67269571 |
| 29 | MAPK12 | 1.65562811 |
| 30 | INSRR | 1.62455365 |
| 31 | MAP3K4 | 1.59823682 |
| 32 | MARK1 | 1.52537783 |
| 33 | PTK2B | 1.49397467 |
| 34 | ICK | 1.48397017 |
| 35 | TGFBR1 | 1.46691019 |
| 36 | EPHB2 | 1.46174029 |
| 37 | PRKD3 | 1.40835995 |
| 38 | PRKCH | 1.38567982 |
| 39 | ERBB2 | 1.32808583 |
| 40 | NEK1 | 1.32421285 |
| 41 | RPS6KA4 | 1.32001366 |
| 42 | SGK223 | 1.31659301 |
| 43 | SGK494 | 1.31659301 |
| 44 | MAPKAPK3 | 1.30722440 |
| 45 | PIK3CG | 1.28069869 |
| 46 | MARK3 | 1.25131937 |
| 47 | PRKCZ | 1.22764983 |
| 48 | CAMKK1 | 1.21027408 |
| 49 | WNK1 | 1.19253853 |
| 50 | GRK5 | 1.14112168 |
| 51 | SGK2 | 1.12170975 |
| 52 | STK24 | 1.10933568 |
| 53 | SGK3 | 1.07173266 |
| 54 | NLK | 1.06687030 |
| 55 | JAK1 | 1.04006498 |
| 56 | FER | 1.03839779 |
| 57 | BTK | 0.99531656 |
| 58 | PLK2 | 0.95074445 |
| 59 | LRRK2 | 0.94941461 |
| 60 | TTK | 0.92410711 |
| 61 | PRKAA1 | 0.91440647 |
| 62 | ABL2 | 0.87994515 |
| 63 | FES | 0.86662150 |
| 64 | SMG1 | 0.84785747 |
| 65 | CAMK2D | 0.84641193 |
| 66 | DYRK1A | 0.84330391 |
| 67 | MAP3K3 | 0.84206934 |
| 68 | GSK3A | 0.83715185 |
| 69 | NEK2 | 0.83056437 |
| 70 | PRKACG | 0.82693856 |
| 71 | AKT3 | 0.82613770 |
| 72 | MYLK | 0.81398880 |
| 73 | LATS1 | 0.80089333 |
| 74 | RPS6KA3 | 0.79894878 |
| 75 | PRKAA2 | 0.78384828 |
| 76 | TYK2 | 0.78139985 |
| 77 | CCNB1 | 0.75593513 |
| 78 | SCYL2 | 0.75507488 |
| 79 | * PRKCB | 0.74714741 |
| 80 | DYRK1B | 0.72392602 |
| 81 | PHKG1 | 0.71894105 |
| 82 | PHKG2 | 0.71894105 |
| 83 | CDK5 | 0.70799437 |
| 84 | PRKD2 | 0.70001674 |
| 85 | IRAK1 | 0.69791607 |
| 86 | JAK2 | 0.67515446 |
| 87 | CAMK1 | 0.67096275 |
| 88 | SGK1 | 0.66184241 |
| 89 | CDK3 | 0.63507325 |
| 90 | MINK1 | 0.61518218 |
| 91 | MAP3K7 | 0.61152800 |
| 92 | GSK3B | 0.60563017 |
| 93 | MAPK3 | 0.60257484 |
| 94 | MAPK4 | 0.60105468 |
| 95 | SIK1 | 0.60044911 |
| 96 | STK3 | 0.59231438 |
| 97 | STK11 | 0.57689050 |
| 98 | AKT2 | 0.57679013 |
| 99 | MAP2K4 | 0.57598899 |
| 100 | MAP2K7 | 0.57336077 |
| 101 | CAMK4 | 0.56624504 |
| 102 | CDK9 | 0.56554699 |
| 103 | * CSNK1D | 0.56319249 |
| 104 | MAPK10 | 0.56063810 |
| 105 | PAK2 | 0.55445166 |
| 106 | MAPK14 | 0.54791287 |
| 107 | PLK3 | 0.54287075 |
| 108 | PRKG1 | 0.53502724 |
| 109 | NTRK3 | 0.53357366 |
| 110 | MAPK9 | 0.53025830 |
| 111 | ALK | 0.52315030 |
| 112 | PRKCG | 0.47962829 |
| 113 | FRK | 0.47355664 |
| 114 | CAMK2A | 0.46622669 |
| 115 | PKN1 | 0.46496012 |
| 116 | CDK1 | 0.45872420 |
| 117 | FGFR4 | 0.43449658 |
| 118 | PDGFRA | 0.42734055 |
| 119 | PRKCD | 0.42013343 |
| 120 | PRKACA | 0.41987118 |
| 121 | PDPK1 | 0.39735832 |
| 122 | UHMK1 | 0.38661346 |
| 123 | WNK4 | 0.37677512 |
| 124 | CDC42BPA | 0.37408501 |
| 125 | CSNK1E | 0.36450469 |
| 126 | RPS6KB1 | 0.36052617 |
| 127 | PTK2 | 0.35324122 |
| 128 | HCK | 0.35196167 |
| 129 | NEK6 | 0.33803377 |
| 130 | MAPK8 | 0.33118676 |
| 131 | PKN2 | 0.33071775 |
| 132 | CHEK2 | 0.32703698 |
| 133 | ARAF | 0.32520508 |
| 134 | ZAP70 | 0.30647405 |
| 135 | MAP3K9 | 0.30372662 |
| 136 | * PRKDC | 0.30366796 |
| 137 | MET | 0.29526996 |
| 138 | BMX | 0.29047489 |
| 139 | RET | 0.28922463 |
| 140 | ROCK1 | 0.28741822 |
| 141 | KSR2 | 0.28716886 |
| 142 | PRKD1 | 0.28520303 |
| 143 | SRC | 0.27924585 |
| 144 | BRAF | 0.27906343 |
| 145 | RIPK1 | 0.27029473 |
| 146 | TEC | 0.26638457 |
| 147 | * PRKCA | 0.26514028 |
| 148 | FYN | 0.26220792 |
| 149 | ATM | 0.26177514 |
| 150 | MAP3K1 | 0.25649152 |
| 151 | NTRK2 | 0.25310339 |
| 152 | CDK15 | 0.24936749 |
| 153 | PDK1 | 0.24820232 |
| 154 | FGFR3 | 0.24173943 |
| 155 | MAPK1 | 0.23841198 |
| 156 | SYK | 0.23188285 |
| 157 | DMPK | 0.23106857 |
| 158 | MAPKAPK2 | 0.22018523 |
| 159 | PDGFRB | 0.21832093 |
| 160 | PIK3CA | 0.21159358 |
| 161 | MOS | 0.20341806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Phototransduction_Homo sapiens_hsa04744 | 15.8195469 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.64459412 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.47073844 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37164079 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26463353 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22861014 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15591740 |
| 8 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91763376 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88961427 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86124877 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84004670 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83932462 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81807065 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 0.80105028 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78972183 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78149128 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75991730 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75138738 |
| 19 | Malaria_Homo sapiens_hsa05144 | 0.73171352 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72235456 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70833847 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 0.68607083 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65775071 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62423888 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60930360 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 0.60107654 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56096680 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53647771 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51931412 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51884126 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49219976 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 0.48904792 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47536295 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47322279 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43527705 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43285941 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41680954 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41083037 |
| 39 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41042506 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 0.39314204 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39060299 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38182474 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37850436 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37733733 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 0.37093951 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36842350 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.36708636 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.36692841 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35335351 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.34991669 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34881566 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34115865 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34110566 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33701795 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33307285 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32604644 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32281777 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31781322 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31530993 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31104818 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.30893198 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30172311 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30105434 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29956821 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.28099469 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27999359 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27822358 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27161106 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27047135 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26818661 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.26301474 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25654873 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25052712 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24493883 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24297750 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23905635 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23412964 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22900869 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22702207 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.21902159 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21686201 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21460263 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21319758 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.21149780 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20826618 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19867657 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19432044 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18606959 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18438119 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18272960 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17734682 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17193992 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16816169 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16596350 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16171688 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16168894 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16110852 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.16085596 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15754382 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.15585945 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15334679 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.15281648 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.15214910 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14826348 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14370892 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.14145751 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14098351 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.13749105 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.13638993 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12993402 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.11963410 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11619531 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.11437617 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10990894 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10755611 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.10563926 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.10382587 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10375308 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.09649948 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09600632 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09263257 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.09238448 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.09178264 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.08869471 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08747650 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08733492 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.08435908 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08046964 |
| 129 | Lysosome_Homo sapiens_hsa04142 | 0.07041656 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.06980080 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06917380 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06884485 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.06585798 |
| 134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.06514055 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.06308160 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.06098082 |
| 137 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.05957602 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.05539495 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05375586 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.04997673 |
| 141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04304464 |
| 142 | Melanogenesis_Homo sapiens_hsa04916 | 0.03824268 |
| 143 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03609728 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.03510315 |
| 145 | Endocytosis_Homo sapiens_hsa04144 | 0.03426001 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.03065863 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.02871380 |
| 148 | Taste transduction_Homo sapiens_hsa04742 | 0.02759652 |
| 149 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.02437754 |
| 150 | Gap junction_Homo sapiens_hsa04540 | 0.02250931 |

